Cannabis companies queue up to join London’s budding subsectorPosted by On


London’s cannabis sector is finally budding two decades after GW Pharma blazed a trail, with debutants MGC Pharmaceuticals and Kanabo Group both warmly welcomed after listing this month

Interest in cannabis stocks sparked into life this month as London welcomed its first two specialist medical marijuana companies.

A surge in share prices was seen around the world last week, as the Reddit-inspired retail investors and YOLO traders jumped aboard the cannabis bandwagon, but a day later and most of the share prices were back to where they started.

To be fair, the self-dubbed ‘degenerates’ of the WallStreetBets online forum were probably joined by many other investors in taking an interest in the sector, as there has been a rush of news flow recently.

Most of the buzz came from a couple of fat M&A deals, namely the US$7.2bn deal to take over Anglo-US group  PLC (NASDAQ:GWPH) struck by Jazz Pharmaceuticals () this month and the planned US$4bn roll-up between Tilray and Aphria.

While interest in the US cannabis sector has been growing since Joe Biden closed in on the White House, British investors found somewhere to get their fix with the initial public offers in the past fortnight of () and PLC (). 

What’s happened?

Before we look at the players in this nascent London sub-sector, it is probably best to look at why they are coming on the market now.

In short, it is a heady mix of legislative and regulatory changes, along with the current market hunger for…

Original Author Link click here to read complete story..

London’s cannabis sector is finally budding two decades after GW Pharma blazed a trail, with debutants MGC Pharmaceuticals and Kanabo Group both warmly welcomed after listing this month

Interest in cannabis stocks sparked into life this month as London welcomed its first two specialist medical marijuana companies.

A surge in share prices was seen around the world last week, as the Reddit-inspired retail investors and YOLO traders jumped aboard the cannabis bandwagon, but a day later and most of the share prices were back to where they started.

To be fair, the self-dubbed ‘degenerates’ of the WallStreetBets online forum were probably joined by many other investors in taking an interest in the sector, as there has been a rush of news flow recently.

Most of the buzz came from a couple of fat M&A deals, namely the US$7.2bn deal to take over Anglo-US group  PLC (NASDAQ:GWPH) struck by Jazz Pharmaceuticals () this month and the planned US$4bn roll-up between Tilray and Aphria.

While interest in the US cannabis sector has been growing since Joe Biden closed in on the White House, British investors found somewhere to get their fix with the initial public offers in the past fortnight of () and PLC (). 

What’s happened?

Before we look at the players in this nascent London sub-sector, it is probably best to look at why they are coming on the market now.

In short, it is a heady mix of legislative and regulatory changes, along with the current market hunger for…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.